- Careers
- Media & Events
- Downloads
-
- Europe
- Belgium
- Germany
- United Kingdom
- France
- Norway
- Austria
- Switzerland
- Czech Republic
- North America
- Canada
- USA
- Middle East & Africa
- United Arab Emirates
- Saudi Arabia
02.03.2026 | News
Construction is progressing at pace on One North Quay in London, set to become Europe’s tallest and most technically advanced commercial life sciences building. Located within the dense urban landscape of Canary Wharf, the project sits on a highly constrained site surrounded by water, existing infrastructure, and limited access routes - exactly the kind of environment where WOLFF luffing cranes excel.
To deliver this landmark scheme, our client Kilnbridge deployed a combination of their own WOLFF tower crane and WOLFFKRAN ‑ supplied cranes: two WOLFF 355 B units and a WOLFF 700 B.
A Complex Lifting Strategy for a Complex Site
The crane scheme required careful planning to support the slipform operations and the demands of a 23 ‑ storey final structure.
TC1 (WOLFF 355 B) was the first crane installed, erected by mobile crane to 46 metres. It slipformed the main core, climbing and tying to the structure four times to reach a final height of 136 metres.
Once TC1 was operational, it erected TC2 (Kilnbridge’s WOLFF 355 B) to a freestanding height of 63 metres. TC2 then climbed and tied four times to reach 135 metres, enabling slipform works on the second tower.
After TC1 slipformed the core to its full height, it was used to erect TC3 (WOLFF 700 B) to 123.7 metres, supported by two ties installed into the core. As part of the same operation, TC3 immediately dismantled TC1. TC2 and TC3 remain on site, supporting the ongoing superstructure works.
At project completion, TC3 will dismantle TC2. TC3 will then be climbed down to 37.8 metres, allowing safe removal by a reasonably sized mobile crane, saving both time and cost.
A Landmark for London’s Scientific Future
One North Quay will become Europe’s tallest purpose ‑ built life sciences building, delivering advanced laboratory and research space for global companies, universities, and fast ‑ growing biotech and technology firms. The development is a major step in expanding London’s life sciences infrastructure and strengthening the city’s position as a leading centre for scientific research and innovation.